P2Y12 Inhibitors May Be the Better Option for Secondary Prevention in CAD

(MedPage Today) -- BARCELONA -- Patients with documented coronary artery disease (CAD) saw cardiovascular benefits with P2Y12-inhibitor monotherapy when compared with aspirin alone, according to the PANTHER meta-analysis. The study's primary...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news